Lilly forecasts 2025 profit above estimates on weight-loss drug strength

Q: How long will it take to read this news story?

The story "Lilly forecasts 2025 profit above estimates on weight-loss drug strength" has 435 words across 20 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Lilly forecasts 2025 profit above estimates on weight-loss drug strength" was covered 9 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 330 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #25927087</li><li>URL: https://chronographically.beamstart.com/news/lilly-forecasts-2025-profit-above-17388475527737</li></ul>

Business Standard Logo Business Standard 9h ago

Lilly forecasts 2025 profit above estimates on weight-loss drug strength - Business Standard

Quick Summary:

The company's shares, which have been subdued since October, rose about 3 per cent in premarket trading.

Both the drugmakers have seen rapid growth in recent years, fueled by investor interest in their weight-loss and diabetes treatments.

Danish rival Novo Nordisk's on Wednesday forecast a slower growth this year compared to 2024, and said it saw "intact strong demand for obesity treatments" in the U.S.and elsewhere.